The annotation and function of the Parkinson's and Gaucher disease-linked gene GBA1 has been concealed by its protein-coding pseudogene GBAP1
Emil Karl GustavssoniD, Siddharth SethiiD, Yujing GaoiD, Jonathan BrentoniD, Sonia García-RuiziD, David ZhangiD, Raquel GarzaiD, Regina Hertfelder ReynoldsiD, James R. EvansiD, Zhongbo CheniD, Melissa Grant‐PetersiD, Hannah L. MacphersoniD, Kylie MontgomeryiD, Rhys DoreiD, Anna I. WernickiD, Charles ArberiD, Selina WrayiD, Sonia GandhiiD, Julian EsselborniD, Cornelis BlauwendraatiD, Christopher H. DouseiD, Anita AdamiiD, Diahann A. M. AtachoiD, Antonina KouliiD, Annelies QuaegebeuriD, , Mina RyteniD
Abstract
The human genome contains numerous duplicated regions, such as parent-pseudogene pairs, causing sequencing reads to align equally well to either gene. The extent to which this ambiguity complicates transcriptomic analyses is currently unknown. This is concerning as many parent genes have been linked to disease, including GBA1, causally linked to both Parkinsons and Gaucher disease. We find that most of the short sequencing reads that map to GBA1, also map to its pseudogene, GBAP1. Using long-read RNA-sequencing in human brain, where all reads mapped uniquely, we demonstrate significant differences in expression compared to short-read data. We identify novel transcripts from both GBA1 and GBAP1, including protein-coding transcripts that are translated in vitro and detected in proteomic data, but that lack GCase activity. By combining long-read with single-nuclear RNA-sequencing to analyse brain-relevant cell types we demonstrate that transcript expression varies by brain region with cell-type-selectivity. Taken together, these results suggest a non-lysosomal function for both GBA1 and GBAP1 in brain. Finally, we demonstrate that inaccuracies in annotation are widespread among parent genes, with implications for many human diseases.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 30
- FWCI
- 7.92
- Field percentile
- top 2%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Comprehensive analysis of GBA using a novel algorithm for Illumina whole-genome sequence data or targeted Nanopore sequencing
Marco Toffoli, Xiao Chen, … Christos Proukakis·Communications BiologyPeer-reviewed·Jul 6, 2022
- Is Gauchian genotyping of GBA1 variants reliable?
Nahid Tayebi, Jens Lichtenberg, … Ellen Sidransky·Communications BiologyPeer-reviewed·May 9, 2025
- An overlooked distal regulatory signal on a shared haplotype drives the neuroinflammatory cascade underlying GBA1-associated Parkinson's disease
Rahel Feleke, Winston Lau, … Nikolas Maniatis·bioRxiv·Jul 13, 2026
- Nanopore sequencing of the glucocerebrosidase (GBA) gene in a New Zealand Parkinsons disease cohort
Oscar E.E. Graham, Toni L. Pitcher, … Martin Alexander Kennedy·Parkinsonism & Related DisordersPeer-reviewed·Nov 29, 2019
- African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1
Pilar Álvarez Jerez, Peter Wild Crea, … Cornelis Blauwendraat·Nature Structural & Molecular BiologyPeer-reviewed·Dec 1, 2024
- Accurate long-read sequencing identified GBA variants as a major genetic risk factor in the Luxembourg Parkinson's study
Sinthuja Pachchek, Zied Landoulsi, … Rejko Krüger·medRxiv·Mar 29, 2023